DATUK MOHD RADZIF BIN MOHD YUNUS

Malaysia

Male

62

Non Active

-Diploma in Land Survey, Universiti Teknologi Malaysia (UTM)
-Bachelor of Applied Science Property Resource Management University of South Australia (SAIT)

Datuk Mohd Radzif comes from a diverse management background. He started his career in academia as a lecturer in Universiti Teknologi Malaysia before following this up with a stint in an international consultancy firm. From here he joined the senior management of a financial institution and thereafter took up the position of Chief Executive Officer of a local conglomerate involved in diversified businesses. Being driven by his entrepreneurial spirit, Datuk Mohd Radzif ventured into his own business but he was soon back to serving a higher purpose when he was called to take up the position of Chief Executive Officer of two pilgrimage fund companies, as part of the companies' turnaround exercise.
This was achieved within 18 months of his appointment date. Subsequently, the Government appointed him as the Chief Executive Officer of Institut Jantung Negara Sdn Bhd (National Heart Institute) effective September 2003. In 2006, he assumed duties as the Group Managing Director of IJN Holdings Sdn Bhd and in charge of three companies as its Group Managing Director and Chief Executive Officer including Institut Jantung Negara Sdn Bhd, IJN Capital Sdn Bhd and IJN College Sdn Bhd. His diversified job exposure in taking charge of international healthcare, property company and the financial institution had proven his leadership ability in the fraternity. As Group Managing Director of SME Bank, he has managed to gain acceptance internationally as part of a global DFI group; The Montreal Group representing Malaysia and ASEAN.
Datuk Mohd Radzif currently serves as a Board member of four (4) Public Listed Companies i.e. Duopharma Biotech Berhad, HeiTech Padu Berhad, SMRT Holdings Berhad and KPJ Healthcare Berhad.

1) DuoPharma Biotech Berhad
2) HeiTech Padu Berhad